Based on an integrative analysis using genomic data of 21 cancer types from TCGA, we identified biological factors contributing to racial disparity in cancer: XKR9 gene expression is significantly associated with overall survival for all cancers combined as well as for several individual cancers, suggesting that XKR9 could be a novel drug target for cancer immunotherapy. The gene discussed is XKR9; the disease is cancer.